Analyte Sensor Membrane Reduces Non-Constant Noise

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional self-monitoring blood glucose (SMBG) methods for diabetics are uncomfortable and inconvenient, leading to infrequent measurements, which can result in delayed detection of hyperglycemic or hypoglycemic conditions, hindering timely insulin therapy decisions.

Innovation Solution

An electrochemical analyte sensor configured for continuous glucose monitoring, featuring a membrane system that reduces noise contributions from non-constant, non-analyte-related components, allowing for accurate and sustained glucose level detection, with a signal contribution of analyte-related components exceeding 80% over extended periods.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional SMBG methods are used, then the measurement process is simple, but the measurement frequency is too low leading to delayed detection of glycemic conditions

Engineering Contradiction:
Improvemeasurement frequencyVSAvoidcomfort and convenience
Core Design Contradiction:
ProductivityVSEase of operation

Solution Approach 1:

The patent replaces the mechanical finger-pricking SMBG method with an implantable electrochemical sensor system that continuously monitors glucose levels in interstitial fluid, eliminating the need for repeated manual blood sampling while enabling continuous high-frequency measurements

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent uses interstitial fluid as an intermediary medium to indirectly measure blood glucose levels, allowing continuous monitoring without direct blood sampling, thereby improving measurement frequency while maintaining patient comfort

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If continuous monitoring is implemented, then measurement precision is improved, but noise from non-constant non-analyte-related components affects signal quality

Engineering Contradiction:
Improveglucose level detection accuracyVSAvoidnoise interference
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The patent extracts and removes noise-causing interfering species from the sensor signal through selective chemical reactions and filtration techniques, separating the analyte-related signal from non-constant noise components to improve measurement precision

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent changes the electrochemical parameters of the sensor system, including applied potential and reaction conditions, to optimize the detection of analyte-related signals while minimizing the impact of non-constant noise from interfering species

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The sensor provides reliable, continuous glucose monitoring with minimal noise interference, enabling diabetics to make informed insulin therapy decisions in a timely manner, reducing the risk of dangerous glycemic events.

Implementation Method 1

the sensor is configured such that the substantially non-constant non-analyte related component does not substantially contribute to the signal, after sensor break-in

Methodology Applied
Scientific EffectSelective transport: Semipermeable Membrane

Implementation Method 2

at least one electrode configured to measure an analyte concentration substantially continuously

Methodology Applied
Scientific EffectElectrochemical measurement: Electrochemiluminescence

Data Source

PatentUS9763609B2Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
Publication Date: 2017.09.19 DEXCOM INC
  • US9763609B2 patent drawing
  • US9763609B2 patent drawing
  • US9763609B2 patent drawing

AI summary

Systems and methods of use involving sensors having a signal-to-noise ratio that is substantially unaffected by non-constant noise are provided for continuous analyte measurement in a host. In some embodiments, a continuous analyte measurement system is configured to be wholly, transcutaneously, intravascularly or extracorporeally implanted.